[The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000378:metabolism*; D000818:Animals; D005243:Feces / Q000032:analysis; D005260:Female; D006207:Half-Life; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D011412:Propanolamines / Q000008:administration & dosage / Q000378:metabolism*; D051381:Rats
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines
Untersuchungen zur Pharmakokinetik von 1-[4-Cyclohexylureidophenoxy]-2-hydroxy-3-tert.-butylaminopropan (Talinolol, Cordanum, 02-115)